Carcinoma of lung | Malignant Neoplasm Thymic | Study Subject Participation Status | Treatment Protocols Specified | Non-Small Cell Lung Carcinoma | Thymoma
Item
subjects with pathology proven lung cancer or thymic malignancy already enrolled in an nci treatment protocol usingazd6244 in nsclc and imc-a12, in thymoma.
boolean
C0684249 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0040113 (UMLS CUI [2,2])
C2348568 (UMLS CUI [3])
C0040808 (UMLS CUI [4,1])
C0205369 (UMLS CUI [4,2])
C0007131 (UMLS CUI [5])
C0040100 (UMLS CUI [6])
Age
Item
participant must be 18 years or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance score of 0 to 2
boolean
C1520224 (UMLS CUI [1])
Informed Consent | Comprehension Study Protocol
Item
ability to provide informed consent. all patients must sign a document of informed consent indicating their understanding of the investigational nature and risks of this study before any protocol related studies are performed.
boolean
C0021430 (UMLS CUI [1])
C0162340 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
Pregnancy Absent | Planned Pregnancy Absent | (18F) fluorothymidine Injection
Item
participants must not be pregnant or intend to become pregnant within 1 week of the last injection of (18)f flt
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0032992 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1432709 (UMLS CUI [3,1])
C1533685 (UMLS CUI [3,2])
Hypersensitivity (18F) fluorothymidine
Item
known allergy to fluorothymidine
boolean
C0020517 (UMLS CUI [1,1])
C1432709 (UMLS CUI [1,2])
Enrollment Causing Delay Standard of Care
Item
participants for whom enrollment would significantly delay (> 2 weeks) the scheduled standard of care therapy
boolean
C1516879 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C0205421 (UMLS CUI [1,3])
C2936643 (UMLS CUI [1,4])
Comorbidity Interferes with Procedure Investigational | Mental condition Interferes with Procedure Investigational | Comorbidity Interferes with Research results | Mental condition Interferes with Research results
Item
participants with any coexisting medical or psychiatric condition that is likely to interfere with study procedures and/or results are excluded
boolean
C0009488 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])
C1517586 (UMLS CUI [1,4])
C3840291 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0184661 (UMLS CUI [2,3])
C1517586 (UMLS CUI [2,4])
C0009488 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0683954 (UMLS CUI [3,3])
C3840291 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0683954 (UMLS CUI [4,3])
Claustrophobia Severe | Anti-Anxiety Agents Unsuccessful | Body Weight Inappropriate Scanner Device
Item
participants with severe claustrophobia not relieved by oral anxiolytic medication or patients weighing > 136 kg (weight limit for scanner table)
boolean
C0008909 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0040616 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])
C0005910 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C1710020 (UMLS CUI [3,3])
Other medical condition Ineligibility Protocol procedure
Item
other medical conditions deemed by the pi or associates to make the patient ineligible for protocol procedures
boolean
C3843040 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0184661 (UMLS CUI [1,4])